Amphista_Horiz_Logo_RGB_1500px.png
Amphista Therapeutics announces new data demonstrating in vivo efficacy and CNS activity of its mechanistically differentiated targeted protein degraders
January 24, 2024 07:00 ET | Amphista Therapeutics
         PRESS RELEASE Amphista Therapeutics announces new data demonstrating in vivo efficacy and CNS activity of its mechanistically differentiated targeted protein degraders First...
Amphista_Horiz_Logo_RGB_1500px.png
Amphista Therapeutics announces new data demonstrating in vivo efficacy and CNS activity of its mechanistically differentiated targeted protein degraders
January 24, 2024 03:00 ET | Amphista Therapeutics
         PRESS RELEASE Amphista Therapeutics announces new data demonstrating in vivo efficacy and CNS activity of its mechanistically differentiated targeted protein degraders First...
Statement from Dr. Jonathan Milner on the suspension of the “Vote AGAINST” campaign
November 01, 2023 07:00 ET | Jonathan Milner
Statement from Dr. Jonathan Milner on the suspension of the “Vote AGAINST” campaign CAMBRIDGE, England, 1 November 2023 - Jonathan Milner, the founder and one of the largest investors in Abcam plc...
Arecor logo.jpg
Arecor: Business Update
July 20, 2023 07:00 ET | Arecor Therapeutics plc
Arecor Therapeutics plc(“Arecor” or the “Group”) BUSINESS UPDATE Strong pipeline of revenue-generating collaborations with major pharmaceutical and biotech companies with further deals anticipated...
Surface Logo_rgb[3].jpg
Coherus to Acquire Surface Oncology
June 16, 2023 07:01 ET | Surface Oncology, Inc.
– Surface acquisition and potential toripalimab approval will transform Coherus into an I-O company with multiple next-generation immunotherapies in clinical development funded by growing revenues – ...
CodeMasters logo.JPG
OBSS CodeMaster coding contest continues with Cambridge after Oxford
March 28, 2023 05:00 ET | OBSS TEKNOLOJI ANONIM SIRKETI
Business simulation coding contest takes place in world-class universities in the UK: Oxford, Cambridge and Imperial College, offering €30,000 grand prize Top 3 Oxford students received their prizes...
Surface Logo_rgb[3].jpg
Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2022
March 09, 2023 07:00 ET | Surface Oncology, Inc.
SRF388 clinical program advancing well; updated clinical data expected in the first half of 2023 First patient dosed in a Phase 1/2 study evaluating SRF114, a potential best-in-class anti-CCR8...
CodeMasters logo.JPG
OBSS CodeMaster expands into the UK, coding contest takes place in Oxford & Cambridge with €30,000 grand prize
March 03, 2023 07:00 ET | OBSS TEKNOLOJI ANONIM SIRKETI
Software development and technology company OBSS Technology, conducts CodeMaster coding contest with a legacy of more than 10 years. On its 11th year, OBSS CodeMaster online coding contest expands...
cropped-cropped-LEX_logo_350-e1641806814611-1.png
LEX Diagnostics Appoints Scott O’Brien as LEX Board member
February 21, 2023 05:14 ET | LEX Diagnostics
CAMBRIDGESHIRE, United Kingdom, Feb. 21, 2023 (GLOBE NEWSWIRE) -- LEX Diagnostics (LEX) today announces the appointment of Scott O’Brien to the LEX Board. The company is revolutionising molecular...
BioNTech Announces S
BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030
January 05, 2023 19:01 ET | BioNTech SE
Multi-year collaboration focuses on three strategic pillars: cancer immunotherapies, infectious disease vaccines, and expansion of BioNTech’s footprint in the UKBioNTech aims to design and roll out...